To evaluate the feasibility of the combined use of virtual histology (VH)-intravascular ultrasound (IVUS) and optical coherence tomography (OCT) for detecting in vivo thin-cap fibroatheroma (TCFA).
Introduction
Acute coronary syndrome (ACS) commonly results from plaque rupture, 1 -3 and occasionally results from erosion or calcified nodules. 4, 5 The pathologic features of plaque prone to rupture are a positively remodelled vessel, including a large necrotic core, a thin fibrous cap (,65 mm), and macrophage infiltration into the cap. 2, 3 This entity is usually known as thin-cap fibroatheroma (TCFA). The accurate detection of TCFA is vital for the diagnosis of vulnerable patients. New imaging modalities, such as virtual histology (VH)-intravascular ultrasound (IVUS) and optical coherence tomography (OCT), were developed to precisely evaluate coronary plaques. Radiofrequency data analysis by VH-IVUS allows for atherosclerotic plaques to be classified as one of the four different types (fibrous, fibro-fatty, dense calcium, and necrotic core), and is especially useful for quantifying the necrotic core. 6, 7 VH-IVUS cannot visualize the thin fibrous cap, however, because of its limited resolution (.100 mm). OCT, on the other hand, can provide a high resolution image (10 -20 mm) , but its penetration is limited (,2 mm). 8 -11 OCT can visualize the thin fibrous cap, but is not able to detect a large and deep lipid core. Thus, it is difficult to diagnose TCFA using each modality alone. The combined use of these complementary imaging modalities, VH-IVUS and OCT, might result in more effective detection of TCFA.
The aim of this study was to elucidate the feasibility of the combined use of VH-IVUS and OCT to detect in vivo TCFA and to clarify the lesion characteristics of TCFA.
Methods

Patient and lesion population
Between August 2005 and March 2007, 402 patients with de novo ischaemic heart disease underwent coronary angiography in our hospital. Angina pectoris was identified as a significant coronary stenosis causing apparent myocardial ischaemia based on symptoms or electrocardiographic ST-T changes during an angina attack. To ensure safety during the OCT procedure, 121 patients were excluded because they had ST-segment elevation indicating an acute myocardial infarction or unstable angina pectoris warranting emergency percutaneous coronary intervention (PCI). Another 160 patients were excluded because 39 patients had chronic total occlusion, 20 patients had heavily calcified lesions that required rota-ablation, five patients had significant left main disease, and 96 patients had tortuous lesions expected to cause difficulty in advancing the IVUS and OCT catheters. Furthermore, we excluded six patients because they had vessels with a diameter .4.0 mm by angiography, which was too large to occlude blood flow. In the remaining 115 patients, 59 did not consent to the invasive intra-coronary examination, and the remaining 56 allowed us to perform the VH-IVUS and OCT examination. We identified plaques based on the IVUS findings and analysed each plaque using both VH-IVUS and OCT.
We assessed patient characteristics, including age, sex, body mass index, presence of coronary risk factors (hypertension, hyperlipidaemia, diabetes mellitus, smoking), and medication. Hypertension was defined as systolic blood pressure !140 mmHg, diastolic blood pressure !90 mmHg, or use of anti-hypertensive drugs. Hyperlipidaemia was defined as a present or past history of low-density lipoprotein -cholesterol level !140 mg/dl, or use of statin. Diabetes mellitus was defined as a fasting blood sugar .126 mg/dl and haemoglobin A1c !6.4%, or use of anti-diabetic medications (insulin or oral hypoglycaemics).
Binary examinations were performed if the patient experienced a severe angina attack or consented to a 6 month follow-up study (21 patients) . This study was approved by the Ethics Committee of Kobe University.
Quantitative coronary arteriography measurement
Coronary angiogram was performed after intracoronary injection of nitroglycerin (250 mg), and the severity of stenosis was measured with a quantitative coronary arteriography cardiovascular measurement system (CMS-Medis Medical Imaging Systems, Leiden). We assessed traditional lesion types using the American Heart Association/American College of Cardiology's classification, and mapped the plaque location (proximal, mid, or distal vessel) angiographically. Because some plaques were completely undetectable by angiography, information from the IVUS was used to determine the plaque location.
Intravascular ultrasound procedure and quantitative coronary ultrasound measurement A 2.9Fr 20 MHz IVUS catheter (Eagle-Eye TM ; Volcano Therapeutics, Inc., Rancho Cordova, CA, USA) was inserted into the coronary artery more than two-thirds distal, and subsequently pulled back with the aid of motorized pullback system (0.5 mm/s). The IVUS images obtained were digitized for quantitative and qualitative analysis according to the criteria of the American College of Cardiology's Clinical Expert Consensus Document on IVUS.
12 A 3D reconstruction of volumetric gray-scale IVUS data was performed using a semiautomated quantitative coronary ultrasound cardiovascular measurement system (CMS-Medis Medical Imaging Systems). If the patient required PCI, we obtained the IVUS data before the PCI procedure. Plaques in the same artery were considered to be separate lesions if the reference segment between them was .5 mm; otherwise, they were considered to be part of a single lesion.
IVUS data recorded on CD-ROM for off-line analysis were used to calculate the lesion length, lumen volume, vessel volume, and plaque volume (vessel volume -lumen volume) based on manual counterdetection of both the lumen and vessel interfaces in each crosssectional frame. We then used these data to calculate %plaque-volume (plaque volume/vessel volume Â 100) and remodelling index (vessel cross-sectional area of minimum lumen site/averaged reference vessel cross-sectional area).
Virtual histology analysis and definition of intravascular ultrasound-derived thin-cap fibroatheroma
Raw radiofrequency data of these lesions were stored on a DVD for off-line quantitative analysis, and plaques were classified by version 2.0 VH software into fibrotic, fibro-fatty, dense calcium, and necrotic core components. Plaque components were represented as a ratio of plaque volume (%fibrous, %fibro-fatty, %dense-calcium, %necrotic-core). Using a previously reported definition, 13 we defined IVUSderived TCFA as a lesion meeting the following two criteria in at least three consecutive frames: (1) focal necrotic core-rich lesions (%necrotic-core .10%) without evident overlying fibrous tissue and (2) %plaque-volume !40%.
An independent investigator at the Erasmus Medical Center quantified the area of the necrotic core in contact with the lumen (NCCL) as well as the major confluent NCCL area and angle occupied by the NCCL in the lumen circumference using a program implemented in MATLAB TM (MathWorks, Natick, MA, USA). The angle formed by the connected necrotic core pixels on the border of the lumen was measured with respect to the lumen centre of gravity ( Figure 1 ).
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Optical coherence tomography examination and definition of optical coherence tomography-derived thin-cap fibroatheroma After the IVUS procedure, OCT examination was performed as previously described. 8 Briefly, an over-the-wire type occlusion balloon Vulnerable plaque detection with VH-IVUS and OCT catheter (Helios TM , LightLab Imaging Inc., Westford, MA USA) and an OCT imaging, probe (ImageWire TM , LightLab Imaging Inc.) were inserted into the coronary artery more than two-thirds distal. The entire vessel length was imaged with an automatic pullback device at 1 mm/s, and OCT data were recorded on a CD-ROM for off-line analysis.
An OCT image of a signal-poor lesion with an unclear border was diagnosed as a lipid core and a signal-rich homogenous lesion overlying lipid content was diagnosed as a fibrous cap. 9 -11 The thinnest part of the fibrous cap was measured three times and the average value calculated. Because the previous histopathology report revealed that 95% of the fibrous cap thickness near a rupture site was ,65 mm, 15 a lesion whose fibrous cap thickness at the thinnest part was ,65 mm was diagnosed as OCT-derived TCFA.
Comparison of virtual histology-intravascular ultrasound and optical coherence tomography images and definition of definite-thin-cap fibroatheroma
We compared the VH-IVUS and OCT images of identical lesions using the locations of side branches, longitudinal plaque distribution, or calcification as landmarks. If the plaque met the criteria of both the IVUSderived TCFA and OCT-derived TCFA, we diagnosed it as definite-TCFA. If IVUS-derived TCFA did not have a thin fibrous cap (,65 mm) by OCT measurement, we diagnosed it as non-thin-cap IVUS-derived TCFA. If VH-IVUS did not detect an NCCL that was detected by OCT-derived TCFA, the plaque was diagnosed as non-NCCL OCT-derived TCFA.
To assess intra-and inter-observer variability, all VH-IVUS and OCT data were read by two independent observers. The first observer repeated a blind analysis of all the data at two separate time points (with at least 1 month interval between the two analyses). If there was discordance of either the IVUS-or OCT-derived TCFA diagnosis between the two observers, a consensus diagnosis was obtained with repeated off-line readings.
Statistical analysis
This is a pilot study that compared the data between VH-IVUS and OCT. Because a previous study demonstrated that plaque volume, vessel remodelling, necrotic core volume, and circumference were associated with an unstable plaque type, 2, 16 we hypothesized that the factors indicative of thin fibrous cap in IVUS-derived TCFA were %plaque-volume, remodelling index, and angle occupied by NCCL in the lumen circumference. Thus, the sample size was based on the preliminary data obtained in our laboratory and was determined on the basis of the following assumptions: A type-I error of 0.05 (two-sided); power of 80%; difference in the %plaque-volume, remodelling index, and the NCCL angle between definite TCFA and non-thin-cap IVUSderived TCFA of 8.0%, 0.1, and 308, respectively, and a standard deviation of 8.0, 0.12, and 35, respectively. Therefore, the minimum required sample size was 23 lesions in each group. We stopped recruitment at 20 months, because the power of these data was beyond 99.9%. Because of the limited sample size of non-NCCL OCTderived TCFA (eight lesions), the data for this group were considered exploratory. Statview version 5.0 (SAS, Cary, NC, USA) was used for the data analysis. Qualitative data are presented with frequencies and quantitative data are shown as medians (25th and 75th percentiles) or mean + SD when indicated. Comparison of laboratory data between the two groups was performed using the unpaired t-test. If the data were not normally distributed, as determined by Kolmogorov-Smirnov analysis, the data were analysed using a Mann-Whitney test. A two-sided P-value of ,0.05 was considered statistically significant.
Angiographical data, gray-scale IVUS and VH-IVUS data were analysed using random-effects generalized least-squares regression in order to account for repeated measurements on individual patients. Wald's test was used for assessing differences in means between plaque type categories. Fitted models were used in calculating predicted means and their 95% confidence intervals (CIs). For the values in Table 2 , a model with two categories of plaque types (definite-TCFA and non-TCFA) was fit. For the values displayed in Tables 3 and 4, a separate model with four categories of plaque types (definite-TCFA and the three subcategories of non-TCFA plaque types) was fit. Predicted means and CIs for definite-TCFA in Tables 3 and 4 occasionally differ slightly from those in Table 2 , because separate models were used. An adjusted P-value of ,0.0167 (0.05/3, Bonferroni's correction for multiple comparisons) was used as the threshold for significance to avoid an inflated type-I error because three pairwise planned comparisons were made.
To assess the inter-and intra-observer variability, the results were compared using the k-test of concordance for the categorical data and Bland -Altman plot was fulfilled for continuous variables.
Results
Feasibility of virtual histology-intravascular ultrasound and optical coherence tomography examinations
In 56 patients, 82 diseased vessels were observed with VH-IVUS and OCT without any complications. We identified 126 plaques in the 82 diseased vessels. The average procedure time of VH-IVUS and OCT, including preparation of both devices, was 18.7 + 4.4 min. The mean evaluation length by VH-IVUS was 48.6 + 16.3 mm and that measured by OCT was 44.5 + 12.8 mm. The average balloon occlusion time for one-time OCT imaging was 49.8 + 11.4 s.
Identification of intravascular ultrasound-, optical coherence tomography-derived thin-cap fibroatheroma, and definite-thin-cap fibroatheroma Of 126 plaques, VH-IVUS observations identified 61 plaques (48.4%) as IVUS-derived TCFA, and OCT examination diagnosed 36 plaques (28.6%) as OCT-derived TCFA. Twenty-eight (22.2%) of the plaques met both criteria for TCFA and were diagnosed as definite-TCFA. The remaining 33 IVUS-derived TCFA (26.2%) were diagnosed as non-thin-cap IVUS-derived TCFA (mean fibrous cap thickness by OCT was 99.0 + 13.3 mm) and the remaining eight OCT-derived TCFA (6.3%) were diagnosed as non-NCCL OCT-derived TCFA. The positive ratio of VH-IVUS for detecting definite TCFA was 45.9% and that of OCT was 77.8%. A summary of the lesion diagnoses is shown in Figure 2 and representative cases of non-thin-cap IVUS-derived TCFA, Vulnerable plaque detection with VH-IVUS and OCT non-NCCL OCT-derived TCFA, and definite-TCFA are shown in Figure 3A -C, respectively.
Baseline characteristics and laboratory data
At least one definite-TCFA was identified in 24 patients (42.9%) but not in the other 32 patients (57.1%). The baseline characteristics and laboratory data for these two patient groups were summarized in Table 1 . There were no differences in age, sex, body mass index, or cardiac risk factors between the two groups. In the present study, five (8.9%) patients had ACS that did not warrant emergency PCI and most of our study population (91.1%) had stable angina. Among the five ACS patients, three had at least one definite-TCFA.
Although patients without definite-TCFA tended to take statins for a longer duration and their total cholesterol level tended to be lower than that in patients with definite-TCFA (P ¼ 0.07, both), there were no significant differences in the lipid profiles, blood sugar profiles, and high-sensitive C-reactive-protein between the two groups.
Comparison of non-thin-cap fibroatheroma and definite-thin-cap fibroatheroma
The summarized angiographical data, gray-scale IVUS, and VH-IVUS data for non-TCFA and definite-TCFA are shown in Table 2 . There were no differences in lesion type, reference diameter, and minimum lumen diameter between the two groups, but definite-TCFA showed significantly higher %area-stenosis and tended to be located in the proximal part of the vessel (P ¼ 0.007 and P ¼ 0.002, respectively). Based on the gray-scale IVUS analysis, plaque volume and vessel volume of definite-TCFA were significantly higher than those of non-TCFA (P ¼ 0.0001 and P ¼ 0.004, respectively). Also, the values for %plaque-volume and the vessel remodelling index of definite-TCFA were significantly higher than those of non-TCFA (P , 0.0001, both). VH analysis showed that the %necrotic-core of definite-TCFA was significantly higher than that of non-TCFA and %fibrous of definite-TCFA was significantly lower than that of non-TCFA (P ¼ 0.006 and P ¼ 0.01, respectively). 
Vulnerable plaque detection with VH-IVUS and OCT
Comparison of non-thin-cap intravascular ultrasound-derived thin-cap fibroatheroma and definite-thin-cap fibroatheroma
The summarized angiographical data, gray-scale IVUS, and VH-IVUS data for non-thin-cap IVUS-derived TCFA and definite TCFA are shown in Table 3 . There were no differences in angiographical data between the two groups. Definite-TCFA, however, had a significantly larger plaque volume, vessel volume, %plaque-volume, and vessel remodelling index than non-thin-cap IVUSderived TCFA (P ¼ 0.001, P ¼ 0.01, P ¼ 0.0001 and P ¼ 0.0005, respectively). Although there were no significant differences in the ratio of plaque components in the VH-IVUS analysis, definite-TCFA had a significantly larger major confluent NCCL area and a larger total angle occupied by NCCL in the lumen circumference compared with non-thin-cap IVUS-derived TCFA (P ¼ 0.003 and P ¼ 0.0003, respectively).
Comparison of non-necrotic core in contact with the lumen optical coherence tomography-derived thin-cap fibroatheroma and definite-thin-cap fibroatheroma
The summarized angiographical data, gray-scale IVUS, and VH-IVUS data for non-NCCL OCT-derived TCFA and definite TCFA are shown in Table 4 . The sample size of non-NCCL OCTderived TCFA was small, thus we considered these data exploratory, but non-NCCL OCT-derived TCFA had a significantly larger %dense-calcium and vessel volume, and smaller vessel remodelling index than definite-TCFA (P ¼ 0.01, P ¼ 0.01 and P ¼ 0.003, respectively). Furthermore, non-NCCL OCT-derived TCFA had a larger reference diameter and minimum lumen diameter than definite-TCFA (P ¼ 0.002 and P ¼ 0.004, respectively).
Intra-and inter-observer variability
The estimated limit of agreement for the intra-and inter-observer variability in the VH-IVUS and OCT measurements was reasonable based on the Bland-Altman plot (%necrotic-core by VH-IVUS; intra-observer; mean difference: 0.03%, upper two-standard deviation (2SD): 1.63% and lower 2SD: 21.68%, inter-observer; mean difference: 0.10%, upper 2SD; 2.00% and lower 2SD: 21.90%, fibrous cap thickness by OCT; intra-observer; mean difference: 0.6 mm, upper 2SD: 12.2 mm and lower 2SD: 213.4 mm, inter-observer; mean difference: 1.9 mm, upper 2SD: 13.8 mm and lower 2SD: 217.7 mm).
There was little intra-or inter-observer disagreement in the diagnosis of IVUS-derived TCFA (intra-observer; k ¼ 0.87, 95% CI, 0.79-0.96, inter-observer; k ¼ 0.81, 95% CI 0.71-0.91) and in the diagnosis of OCT-derived TCFA (intra-observer; k ¼ 0.87 0.77-0.96, inter-observer; k ¼ 0.77, 0.65-0.90).
Patient follow-up
In 21 patients with binary angiography (11 patients with definite-TCFA and 10 patients without definite-TCFA; 13 lesions were definite-TCFA and 32 lesions were non-TCFA; average span 205.0 + 68.0 days), four lesions required PCI because of increasing plaque size and a constricting lumen, and three of these were definite-TCFA. A representative case of definite-TCFA progression is shown in Figure 4 . 
Discussion
Pathology studies have demonstrated that acute coronary events most commonly arise from the disruption of TCFA. Several imaging modalities, including IVUS, 17 VH-IVUS, 13, 14 angioscopy, 18 elastography, 19 and thermography, 20 have been used to detect TCFA. The sensitivity or specificity of these modalities for the detection of TCFA in vivo, however, has not been satisfactory. Vulnerable plaque detection with VH-IVUS and OCT VH-IVUS for spectral analysis of radio-frequency data has the potential to detect TCFA. VH-IVUS is highly accurate for identifying plaque components both in vitro and in vivo. 6,7 RodriguezGranillo et al. 13 were the first to focus on the distribution of plaque components using VH-IVUS studies. They defined IVUSderived TCFA based on pathologic data and demonstrated that the mean plaque volume and mean %necrotic-core of IVUSderived TCFA were similar to previously reported histopathologic TCFA data. Thus, the ability of VH-IVUS to produce real-time assessment of plaque morphology has been established and might be useful for identifying TCFA. Because the maximum resolution of VH-IVUS is 100 mm, however, it is difficult to assess the thin fibrous cap (,65 mm).
Optical coherence tomography is a new imaging modality for detecting vulnerable plaque. OCT provides a high-resolution image and is able to evaluate detailed plaque morphology in vivo. 8 -11 OCT, therefore, seems to have the potential to visualize the thin fibrous cap and detailed structures. The penetration of OCT is limited (,2 mm), so that it is frequently difficult to delineate large lipid plaques. Manfrini et al. 21 reported that OCT could be unreliable to differentiate areas with heterogenous composition because of its low signal penetration. In our study, eight OCTderived TCFA lesions were not identified as an NCCL by VH-IVUS analysis. This discrepancy might be because of the penetration limitation of OCT. These lesions had a larger reference diameter, minimum lumen diameter, and minimum vessel volume than definite-TCFA (P ¼ 0.002, P ¼ 0.004, P ¼ 0.01, respectively), and had severely calcified components compared with definite-TCFA (P ¼ 0.01). When a target vessel or plaque is large, the optical signal might be attenuated by the plaque and failed to identify plaque morphology. It might also be sometimes difficult to discriminate between lipid and calcified lesions because both these appear as low-intensity images, usually differentiated in OCT by an unclear border (lipid) or a clear border (calcium). In this regard, large calcified lesions are likely to be misdiagnosed as TCFA by OCT examination. Therefore, it is difficult to detect TCFA using only one modality. Using a combination of complementary tools such as VH-IVUS and OCT might be a feasible approach for more accurate detection of TCFA.
Although the positive ratio of VH-IVUS for detecting definite-TCFA was 45.9% and that for OCT was higher than VH-IVUS (77.8%), OCT has several procedural limitations and is only used in selected hospitals. IVUS is now routinely used for PCI procedures. Thus, it is important to determine the criteria for TCFA by VH-IVUS. Previous IVUS and pathological studies showed that positive vessel remodelling is associated with an unstable clinical presentation and characteristic pathologic lesion types. 16, 22, 23 Kolodgie et al. 2 reported that whether the necrotic core is circumferential might be critical for determining the instability of a plaque, and they demonstrated that proximal coronary lesions with greater than 50% diameter stenosis with an necrotic core circumference .1208 strongly suggests the presence of /cm vessel volume, 58.4% %plaque-volume, and 28% %necrotic-core. The fibrous cap thickness of this lesion was 60 mm by OCT measurement and this lesion was diagnosed as definite-TCFA. (B) After 6 months, because the patient experienced chest pain at rest with increased frequency, we performed CAG. The CAG revealed 90% stenosis at the site of the previous definite-TCFA lesion. VH-IVUS revealed an increase in plaque volume (68.8!79.7 mm plaque with a vulnerable morphology. In the present study, definite-TCFA identified by both modalities tended to locate in the proximal part of the vessels, areas with a higher %area-stenosis, %plaque-volume and more positively remodelled lesions in comparison to non-TCFA. These data are compatible with previously reported histopathologic data. 2, 23 Furthermore, the major confluent NCCL area of definite-TCFA was larger and its NCCL occupied a larger circumference of the lumen than non-thin-cap IVUS-derived TCFA. Thus, %plaque-volume, vessel remodelling index, confluent major NCCL area, and degree of NCCL circumference were the identifying factors for definite-TCFA by VH-IVUS. One of the clinical implications of the present study was to identify the VH-IVUS indices useful for diagnosing definite-TCFA.
Limitations
Because patients excluded from the study were those with high risk-ACS, we could not reach any conclusions about the general prevalence of definite-TCFA. Further, we could observe only limited vessel areas, as the VH-IVUS and OCT procedures have several limitations for imaging certain lesions, such as severely calcified tortuous lesions or other complex lesions. Thus, our study results do not represent an unbiased sampling of all coronary arteries, and the detection rate of TCFA in our study patients might be underestimated. There were three cases of definite-TCFA with progression requiring PCI; it is unclear whether the detected definite-TCFA will cause acute coronary events and was a true vulnerable plaque. Although the frequency of the progression was too low to reach any statistical significance, definite-TCFA tended to progress more compared with non-TCFA. Our findings, therefore, should be confirmed with a larger study population and the subsequent course of the lesions observed as well.
In the present study, 61 plaques were identified as IVUS-derived TCFA by VH-IVUS examination. This identification was based on the criteria of a previous published report. 13 This high prevalence of high-risk plaque, however, was at variance with previously published in vivo and in vitro studies, 5, 13 which might be because of inaccurate VH determination by in vitro testing. Further, we selected cut-off values of IVUS-derived TCFA criteria as %plaque-volume .40% and %necrotic-core .10% because pathologic TCFA is very unlikely to be present in segments with ,40% occlusive lesion, and nearly 90% of ruptured plaque comprised .10% necrotic core in the plaque area. 3 We did consider that the necrotic core size of 10% was too low, because the average %necrotic-core of definite-TCFA was 20.0 + 6.8% and that of non-TCFA was 15.3 + 8.6%. This data is in line with the previous pathologic findings in this subset of lesions and also in previous VH-IVUS studies. 2, 3, 14 Thus, TCFA might be over-diagnosed if based on the current definition of IVUS-derived TCFA. Our study population was too small, however, to establish new criteria for defining IVUS-derived TCFA. Although we could perform the VH-IVUS and OCT procedures within 20 min and without complications, the combined use of VH-IVUS and OCT is laborious and costly. A new device with both IVUS and OCT functions to enable the simultaneous use of both modalities should be developed.
Conclusions
This is the first study to evaluate TCFA using a combination of two new imaging modalities, VH-IVUS and OCT. Neither modality alone is sufficient for detecting TCFA. The combined use of these complementary imaging modalities, VH-IVUS and OCT, however, should be considered a feasible approach for more precise detection of TCFA.
